针对选择性化疗的转录复制冲突的小分子向
Long Gu1, Min Li2, Caroline M Li1
1Department of Molecular Diagnostics & Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Cell chemical biology
|August 2, 2023
概括
一个新型的小分子,AOH1996,通过抑制增殖细胞核抗原 (PCNA),选择性地杀死癌细胞,并具有最小的副作用,从而向转录复制冲突.
科学领域:
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
- 基因组学就是基因组学.
背景情况:
- 转录复制冲突是癌症中DNA损伤和基因组不稳定的重要来源.
- 增殖细胞核抗原 (PCNA) 在DNA复制和修复中起着至关重要的作用.
- 针对这些冲突是一个潜在的抗癌治疗策略.
研究的目的:
- 确定和描述一种新的PCNA小分子抑制剂.
- 为了研究AOH1996在癌细胞中的作用机制.
- 在临床前癌症模型中评估AOH1996的治疗潜力.
主要方法:
- 合理药物设计被用来识别PCNA抑制剂AOH1996.
- 这项研究研究了PCNA和RNA聚合酶II亚单元RPB1.1.之间的相互作用.
- 用癌细胞系和瘤模型来评估AOH1996的疗效和安全性.
主要成果:
- AOH1996通过增强PCNA-RPB1相互作用和将PCNA与转录的染色质分离来选择性地诱导癌细胞死亡.
- 这导致了依赖转录的DNA双链断裂.
- 在RPB1的PCNA结合区域的一个点突变赋予了AOH1996.6的抗性.
- AOH1996证明了瘤生长抑制作为单一治疗或组合治疗,没有显著的副作用.
结论:
- AOH1996是一种可口服,代谢稳定的PCNA抑制剂,具有抗癌活性.
- 针对转录复制冲突是癌症治疗的有希望的治疗途径.
- AOH1996利用了一种选择性癌症漏洞,具有广泛应用的潜力.
更多相关视频
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.6K
09:00An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
11.6K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
DNA Helicases
21.5K
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
21.5K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
